Evidence map›Paper›PMID 21559489›Full record

ArticlePloS one2011

Conservation of complex nuclear localization signals utilizing classical and non-classical nuclear import pathways in LANA homologs of KSHV and RFHV.

Lidia Cherezova, Kellie L Burnside, Timothy M Rose

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. KSHV LANA acetylation-selective acidic domain reader sequence mediates virus persistence.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Kaposi's Sarcoma Herpesvirus Genome Persistence.Frontiers in microbiology · 2016
    Review
  13. Article
  14. Article
  15. Article
  16. Viral DNA tethering domains complement replication-defective mutations in the p12 protein of MuLV Gag.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lidia CherezovaDepartment of Global Health, University of Washington, Seattle, Washington, United States of America.
Kellie L Burnside
Timothy M Rose
Seattle Children's Hospital · USUniversity of Washington · US

Funding

ORAL BIOLOGY TRAINING SALIVARY SECRETIONST32DE007023 · NIDCR · UNIVERSITY OF WASHINGTON · PI IZUTSU, KENNETH T · 1985 to 2006
$2.3M
CELLULAR HOMOLOGS IN A NEW SIMIAN GAMMAHERPESVIRUSR01RR013154 · NCRR · UNIVERSITY OF WASHINGTON · PI ROSE, TIMOTHY M · 1997 to 2004
$1.9M
A macaque model for AIDS-related oral malignanciesR21DE016826 · NIDCR · UNIVERSITY OF WASHINGTON · PI ROSE, TIMOTHY M · 2006 to 2007
$416k
NCRR NIH HHS R01 RR013154NCRR NIH HHS RR13154NIDCR NIH HHS DE016826NIDCR NIH HHS DE07023NIDCR NIH HHS R21 DE016826NIDCR NIH HHS T32 DE007023
6 · The paper itself

Abstract

ORF73 latency-associated nuclear antigen (LANA) of the Kaposi's sarcoma-associated herpesvirus (KSHV) is targeted to the nucleus of infected cells where it binds to chromatin and mediates viral episome persistence, interacts with cellular proteins and plays a role in latency and tumorigenesis. A structurally related LANA homolog has been identified in the retroperitoneal fibromatosis herpesvirus (RFHV), the macaque homolog of KSHV. Here, we report the evolutionary and functional conservation of a novel bi-functional nuclear localization signal (NLS) in KSHV and RFHV LANA. N-terminal peptides from both proteins were fused to EGFP or double EGFP fusions to examine their ability to induce nuclear transport of a heterologous protein. In addition, GST-pull down experiments were used to analyze the ability of LANA peptides to interact with members of the karyopherin family of nuclear transport receptors. Our studies revealed that both LANA proteins contain an N-terminal arginine/glycine (RG)-rich domain spanning a conserved chromatin-binding motif, which binds directly to importin β1 in a RanGTP-sensitive manner and serves as an NLS in the importin β1-mediated non-classical nuclear import pathway. Embedded within this domain is a conserved lysine/arginine-(KR)-rich bipartite motif that binds directly to multiple members of the importin α family of nuclear import adaptors in a RanGTP-insensitive manner and serves as an NLS in the classical importin α/β-mediated nuclear import pathway. The positioning of a classical bipartite kr-NLS embedded within a non-classical rg-NLS is a unique arrangement in these viral proteins, whose nuclear localization is critical to their functionality and to the virus life cycle. The ability to interact with multiple import receptors provides alternate pathways for nuclear localization of LANA. Since different import receptors can import cargo to distinct subnuclear compartments, a multifunctional NLS may provide LANA with an increased ability to interact with different nuclear components in its multifunctional role to maintain viral latency.

Indexed as

Nuclear Localization SignalsActive Transport, Cell NucleusAmino Acid MotifsAmino Acid SequenceAnimalsAntigens, Viralbeta KaryopherinsCell NucleusChlorocebus aethiopsConserved SequenceCOS CellsGlutathione TransferaseGreen Fluorescent ProteinsHerpesviridaeHerpesvirus 8, HumanMacacaAntigens, Viralbeta KaryopherinsGlutathione TransferaseGreen Fluorescent Proteinslatency-associated nuclear antigenNuclear Localization SignalsNuclear Proteins

Identifiers

PMID21559489
PMCPMC3084728
OpenAlexW2034477844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.